| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 11.99B | — |
| Operating expense | — | — |
| Net income | 1.74B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TMO returned +26.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +8.8% |
| 1 year | +26.3% |
| 5 years | +15.0% |
| 10 years | +325.5% |
| All-time high | $667.24 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TMO would be worth today ›Yes. Thermo Fisher Scientific Inc paid 4 dividends over the past 12 months. The most recent was $0.47 per share on Jun 15, 2026. The dividend yield is 0.30%.
Thermo Fisher Scientific Inc stock trades on NYSE under the ticker symbol TMO.
Thermo Fisher Scientific Inc is part of the Healthcare sector.
Thermo Fisher Scientific Inc has a market cap of 232.67B USD, based on the latest quote.
Thermo Fisher Scientific Inc is scheduled to report earnings on Oct 21, 2026.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
